COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,442 Articles (22,835 medRxiv, 8,607 bioRxiv)

Most recent first Previous |  Page 2598: Articles 25971-25980  | Next

Cytosine deamination in SARS-CoV-2 leads to progressive CpG depletion.
Sadykov, M., Mourier, T., Guan, Q., Pain, A.
10.1101/2020.06.19.161687 — Posted: 2020-06-19 Discussion: Offsite
Cross-neutralization activity against SARS-CoV-2 is present in currently available intravenous immunoglobulins
Diez, J. M., Romero, C., Vergara Alert, J., Bello Perez, M., Rodon, J., Honrubia, J. M., Segales, J., Sola, I., Enjuanes, L., Gajardo, R.
10.1101/2020.06.19.160879 — Posted: 2020-06-19
Proteotyping SARS-CoV-2 virus from nasopharyngeal swabs: a proof-of-concept focused on a 3 min mass spectrometry window
Gouveia, D., Miotello, G., Gallais, F., Gaillard, J.-C., Debroas, S., Bellanger, L., Lavigne, J.-P., Sotto, A., Grenga, L., Pible, O., Armengaud, J.
10.1101/2020.06.19.161000 — Posted: 2020-06-19
Nucleocapsid protein of SARS-CoV-2 phase separates into RNA-rich polymerase-containing condensates
Savastano, A., Ibanez-de-Opakua, A., Rankovic, M., Zweckstetter, M.
10.1101/2020.06.18.160648 — Posted: 2020-06-19
ARDS and Cytokine Storm in SARS-CoV-2 Infected Caribbean Vervets
Blair, R. V., Vaccari, M., Doyle-Meyers, L. A., Roy, C. J., Russell-Lodrigue, K., Fahlberg, M., Monjure, C. J., Beddingfield, B., Plante, K. S., Plante, J. A., Weaver, S. C., Qin, X., Midkiff, C. C., Lehmicke, G., Golden, N., Threeton, B., Penney, T., Allers, C., Barnes, M. B., Pattison, M., Datta, P. K., Maness, N. J., Birnbaum, A., Bohm, R. P., Rappaport, J.
10.1101/2020.06.18.157933 — Posted: 2020-06-19
Drug repurposing screens reveal FDA approved drugs active against SARS-Cov-2
Dittmar, M., Lee, J. S., Whig, K., Segrist, E., Li, M., Jurado, K., Samby, K., Ramage, H., Schultz, D., Cherry, S.
10.1101/2020.06.19.161042 — Posted: 2020-06-19 Discussion: Onsite | Offsite
A single dose of recombinant VSV-{triangleup}G-spike vaccine provides protection against SARS-CoV-2 challenge
Yahalom-Ronen, Y., Tamir, H., Melamed, S., Politi, B., Shifman, O., Achdout, H., B. Vitner, E., Israeli, O., Milrot, E., Stein, D., Cohen-Gihon, I., Lazar, S., Gutman, H., Glinert, I., Cherry, L., Vagima, Y., Lazar, S., Weiss, S., Ben-Shmuel, A., Avraham, R., Puni, R., Lupu, E., Bar David, E., Sittner, A., Erez, N., Zichel, R., Mamroud, E., Mazor, O., Levy, H., Laskar, O., Yitzhaki, S., C. Shapira, S., Zvi, A., Beth-Din, A., Paran, N., Israely, T.
10.1101/2020.06.18.160655 — Posted: 2020-06-19 Discussion: Onsite
Identification of a critical horseshoe-shaped region in the nsp5 (Mpro, 3CLpro) protease interdomain loop (IDL) of coronavirus mouse hepatitis virus (MHV)
Nick, B. C., Pandya, M. C., Lu, X., Franke, M. E., Callahan, S. M., Hasik, E. F., Berthrong, S. T., Denison, M. R., Stobart, C. C.
10.1101/2020.06.18.160671 — Posted: 2020-06-19
Mechanism and inhibition of SARS-CoV-2 PLpro
Klemm, T., Ebert, G., Calleja, D. J., Allison, C. C., Richardson, L. W., Bernardini, J. P., Lu, B. G. C., Kuchel, N. W., Grohmann, C., Shibata, Y., Gan, Z. Y., Cooney, J. P., Doerflinger, M., Au, A. E., Blackmore, T. R., Geurink, P. P., Ovaa, H., Newman, J., Riboldi-Tunnicliffe, A., Czabotar, P. E., Mitchell, J. P., Feltham, R., Lechtenberg, B. C., Lowes, K. N., Dewson, G., Pellegrini, M., Lessene, G., Komander, D.
10.1101/2020.06.18.160614 — Posted: 2020-06-19 Discussion: Onsite
Development of a SARS-CoV-2 total antibody assay and the dynamics of antibody response over time in hospitalized and non-hospitalized patients with COVID-19
Vogelzang, E. H., Loeff, F. C., Derksen, N. I., Kruithof, S., Ooijevaar-de Heer, P., van Mierlo, G., Linty, F., Mok, J. Y., van Esch, W., de Bruin, S., Vlaar, A. P., Seppen, B., Leeuw, M., van Oudheusden, A. J., Buiting, A. G., Jim, K. K., Vrielink, H., Swaneveld, F., Vidarsson, G., van der Schoot, C. E., Wever, P., Li, W., van Kuppeveld, F. J., Murk, J.-L., Bosch, B. J., Wolbink, G. J., Rispens, T.
10.1101/2020.06.17.20133793 — Posted: 2020-06-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).